PP
GILD icon

Paloma Partners’s Gilead Sciences GILD Stock Holding History

Paloma Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,400
Closed -$782K – 1366
2024
Q2 		$782K Sell
11,400
-129,795
-92% -$8.66M 0.02% 585
2024
Q1 		$10.3M Buy
141,195
+127,995
+970% +$9.84M 0.55% 35
2023
Q4 		$1.07M Sell
13,200
-58,900
-82% -$4.58M 0.04% 405
2023
Q3 		$5.4M Buy
+72,100
New +$5.55M 0.19% 95
2022
Q3 		– Sell
-36,800
Closed -$2.27M – 1138
2022
Q2 		$2.27M Sell
36,800
-308,700
-89% -$19.1M 0.08% 241
2022
Q1 		$20.5M Buy
+345,500
New +$22.1M 0.6% 17
2019
Q4 		– Sell
-7,000
Closed -$444K – 2287
2019
Q3 		$444K Buy
+7,000
New +$458K 0.01% 1247
2019
Q2 		– Sell
-75,700
Closed -$4.92M – 1905
2019
Q1 		$4.92M Buy
+75,700
New +$5.03M 0.12% 177
2018
Q3 		– Sell
-36,400
Closed -$2.58M – 1678
2018
Q2 		$2.58M Sell
36,400
-25,100
-41% -$1.77M 0.05% 356
2018
Q1 		$4.64M Sell
61,500
-41,500
-40% -$3.3M 0.07% 227
2017
Q4 		$7.38M Sell
103,000
-170,700
-62% -$13M 0.1% 170
2017
Q3 		$22.2M Sell
273,700
-248,700
-48% -$19M 0.3% 30
2017
Q2 		$37M Sell
522,400
-206,200
-28% -$13.7M 0.44% 24
2017
Q1 		$49.5M Sell
728,600
-147,400
-17% -$10.4M 0.59% 13
2016
Q4 		$62.7M Buy
876,000
+83,700
+11% +$6.22M 0.61% 14
2016
Q3 		$62.7M Sell
792,300
-338,600
-30% -$27.5M 0.78% 18
2016
Q2 		$94.3M Buy
1,130,900
+221,300
+24% +$19.6M 1.04% 12
2016
Q1 		$83.6M Buy
909,600
+644,000
+242% +$58.1M 1.37% 8
2015
Q4 		$26.9M Buy
265,600
+128,100
+93% +$13.3M 0.71% 13
2015
Q3 		$13.5M Sell
137,500
-224,700
-62% -$25M 0.31% 42
2015
Q2 		$42.4M Buy
+362,200
New +$39.6M 0.82% 13

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Paloma Partners's GILD Position: Q3 2024 in Review

Paloma Partners sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 6,700 shares — an estimated $460K sold.

Paloma Partners first reported a position in GILD in Q2 2013 and held it in 33 quarters. The position peaked at $31.4M in Q2 2016. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Paloma Partners reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Paloma Partners sold 6,700 Gilead Sciences shares in Q3 2024, an estimated $460K.
  • Paloma Partners first reported a position in Gilead Sciences in Q2 2013 and held it in 33 quarters.
  • Paloma Partners's Gilead Sciences position peaked at $31.4M in Q2 2016.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.